Thomas Dyrberg

Director/Board Member at

Lux Biosciences, Inc.

71 year

78 connections

Health Technology

Finance

Consumer Services

Profile

Thomas Dyrberg is currently a Director at Lux Biosciences, Inc., Kanyos Bio, Inc., Nuvelution Pharma, Inc., and Theia, Inc. He is also a Senior Advisor at Novo Holdings AS (Denmark) and a Managing Partner at Novo Ventures 1 A. Previously, he served as the Chief Executive Officer at Novo Nordisk Fonden and the Deputy Chairman at Veloxis Pharmaceuticals A. He has also held positions as Chairman at Hemofocus ApS, Director at Sapphire Therapeutics, Inc., Director at Gloucester Pharmaceuticals, Inc., Director at BioMimetic Therapeutics, Inc., Independent Director at Galera Therapeutics, Inc., Independent Director at IVERIC bio, Inc., Director at AlloCure, Inc., Director at Cell Medica Switzerland AG, Director at PanOptica, Inc., Director at Imagen Biotech, Inc., and Independent Director at Entasis Therapeutics, Inc. Additionally, he worked as a Manager-International Clinical Project at Novo Nordisk A and as a Principal at The Scripps Research Institute.
Dr. Dyrberg holds a doctorate degree from the University of Copenhagen, conferred in 1986 and 1981.

Thomas Dyrberg active positions

Companies	Position	Start
Lux Biosciences, Inc. Lux Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops medicines to treat ophthalmic diseases	Director/Board Member	-
Theia, Inc.	Director/Board Member	-
Novo Holdings A/S (Denmark) Novo Holdings A/S (Denmark) Investment ManagersFinance Functions as an alternative investment manager	Corporate Officer/Principal	-
Kanyos Bio, Inc. Kanyos Bio, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies for type 1 diabetes	Director/Board Member	-

All active positions of Thomas Dyrberg

Former positions of Thomas Dyrberg

Companies	Position	End
Novo Ventures 1 A/S Novo Ventures 1 A/S Investment ManagersFinance Novo Ventures invests in companies located in Europe, the United States and Asia. The firm targets companies operating in the fields of health technology, health services, biotechnology and medical specialties sectors. It provides financing for early stage capital requirements.	Private Equity Investor	01/12/2025
PRAXIS PRECISION MEDICINES, INC.	Director/Board Member	01/10/2020
GALERA T COM USD0.	Director/Board Member	06/11/2019
IVERIC BIO, INC.	Director/Board Member	15/05/2019
VELOXIS PHARMACEUTICALS A/S	Director/Board Member	28/07/2016

See the detail of Thomas Dyrberg's experience

Training of Thomas Dyrberg

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Thomas Dyrberg's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	24
Novo Nordisk A/S Novo Nordisk A/S Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products for diabetes care	Health Technology
Sapphire Therapeutics, Inc. Sapphire Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceutical products	Health Technology
Gloucester Pharmaceuticals, Inc. Gloucester Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops products for the treatment of cancer patients	Health Technology
BioMimetic Therapeutics, Inc. BioMimetic Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and sells protein therapeutics for tissue and organ regeneration	Health Technology
Lux Biosciences, Inc. Lux Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops medicines to treat ophthalmic diseases	Health Technology
Veloxis Pharmaceuticals A/S Veloxis Pharmaceuticals A/S Pharmaceuticals: MajorHealth Technology Develops and commercializes medicines for the prevention of organ rejection in kidney transplant patients	Health Technology
Galera Therapeutics, Inc. Galera Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes drugs to reduce normal tissue toxicity from radiotherapy	Health Technology
Novo Nordisk Fonden Novo Nordisk Fonden Investment Trusts/Mutual FundsMiscellaneous Functions as a foundation	Miscellaneous
Novo Holdings A/S (Denmark) Novo Holdings A/S (Denmark) Investment ManagersFinance Functions as an alternative investment manager	Finance
The Scripps Research Institute The Scripps Research Institute Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
University of Copenhagen University of Copenhagen Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
IVERIC bio, Inc. IVERIC bio, Inc. BiotechnologyHealth Technology Operates as a science-driven biopharmaceutical company that develops novel treatments for retinal diseases	Health Technology
Novo Ventures 1 A/S Novo Ventures 1 A/S Investment ManagersFinance Novo Ventures invests in companies located in Europe, the United States and Asia. The firm targets companies operating in the fields of health technology, health services, biotechnology and medical specialties sectors. It provides financing for early stage capital requirements.	Finance
AlloCure, Inc. AlloCure, Inc. BiotechnologyHealth Technology Develops cell therapies for the treatment of kidney diseases, organ transplants and multi-organ injuries	Health Technology
Hemofocus ApS Hemofocus ApS Medical SpecialtiesHealth Technology Provides anticoagulant products	Health Technology
Cell Medica Switzerland AG Cell Medica Switzerland AG Pharmaceuticals: MajorHealth Technology Researches, develops, manufactures, and distributes pharmaceutical, biological, medical, and diagnostic products	Health Technology
PanOptica, Inc. PanOptica, Inc. Pharmaceuticals: MajorHealth Technology Manufactures ophthalmology drugs for treatment of eye diseases	Health Technology
Imagen Biotech, Inc. Imagen Biotech, Inc. BiotechnologyHealth Technology Develops therapeutics for blinding diseases	Health Technology
Kanyos Bio, Inc. Kanyos Bio, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies for type 1 diabetes	Health Technology
Nuvelution Pharma, Inc. Nuvelution Pharma, Inc. BiotechnologyHealth Technology Provides solutions for R&D companies in the pharmaceutical and biotech industries	Health Technology
Entasis Therapeutics, Inc. Entasis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs for infectious diseases	Health Technology
Theia, Inc.
Praxis Precision Medicines, Inc. Praxis Precision Medicines, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biopharmaceutical company which develops therapies for central nervous system disorders	Health Technology
Entasis Therapeutics Holdings, Inc. Entasis Therapeutics Holdings, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical biopharmaceutical company that engages in development of antibacterial products	Commercial Services